Fundraising FoxByers Capital — Full Portfolio
19 tracked investments · listed companies and verified rows first
Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.
BiotechDeep TechDigital HealthMedical DevicesWatertown, US
Paul L. Berns(Chairman and Chief Executive Officer)Joshua Pinto(Executive Officer)Tamara Tompkins(Executive Officer)inKari Stefansson(Director)Maykin Ho(Director)Alaa Halawa(Director)
Co-investorsARCH Venture PartnersCatalio Capital Management, LPF-Prime CapitalK2 HealthVenturesMercury FundPremier Partners+12 more
Revolutionizing space technology to make life multi-planetary
Hawthorne, US
Elon Musk(Founder)inBret Johnsen(Executive Officer)inGwynne Shotwell(Executive Officer, Director)Tom Mueller(Founder)
BoardAntonio Gracias(Director)inSteve Jurvetson(Director)in
Co-investors1/1 Capital137 Ventures1802 Ventures2080 Ventures3Spoke Capital4DX Ventures+206 more
Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.
BiotechDeep TechHealthtechLeiden, NL
Koenraad Wiedhaup(Founder & Chief Executive Officer)inRonald Brus(Founder & Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)inDinko Valerio(Founder and Chair of the Supervisory Board)inJintanat Ananworanich(Chief Medical Officer)inClarissa Koch(Chief Scientific Officer)in
Co-investorsClavystBioF-Prime CapitalGV (Google Ventures)Bluebird VenturesCasdin CapitalEuropean Innovation Council Fund+7 more
Arsenal Biosciences is a clinical-stage company developing programmable cell therapies to treat solid tumors.
BiotechHealthtechMedical DevicesSouth San Francisco, US
Ken Drazan(Founder)James Ahlers(Executive Officer)Irene Pleasure(Executive Officer)Margaret Nibbi(Executive Officer)Alexander Marson(Founder)Kole Roybal(Founder)
Co-investorsARCH Venture PartnersHitachi VenturesKleiner PerkinsLuma GroupOUP (Osage University Partners)SoftBank Vision Fund+4 more
Benchling provides a cloud-based R&D platform for life sciences, combining a collaborative electronic lab notebook, structured scientific data modeling, automated workflows, and AI tools.
AI & Machine LearningBiotechEnterprise SoftwareSaaSSan Francisco, US
Sajith Wickramasekara(Founder)inAshutosh Singhal(Founder)Ashu Singhal(Founder)inCheng Kang(Founder)Cornelius Chen(Founder)
BoardMiles Grimshaw(Director)in
Co-investorsAlkeon InnovationAndreessen HorowitzArtisanal VenturesBalaji SrinivasanDraper AssociatesEnsemble Labs+31 more
Chai Discovery builds a computer-aided design suite using artificial intelligence to design new molecules and drugs.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Joshua Meier(Founder)inJack Dent(Founder)inJacques Boitreaud(Founder)Jacques Boutreau(Founder)Joshua Meier Jack Dent(Founder)Matt McPartlon(Founder)
Co-investorsAmplify PartnersAvenir Growth CapitalavraBain Capital VenturesBattery VenturesDCVC (Data Collective)+30 more
Culdesac is a real estate developer and neighborhood manager that builds and operates walkable, mixed-use car-free communities designed to foster local business and community engagement.
Construction TechConsumerMobility & TransportationPropTechSan Francisco, US
Jeff Berens(Founder)inRyan Johnson(Founder)in
Co-investorsFloodgateInitialized CapitalSoma CapitalWinklevoss CapitalY CombinatorZigg Capital+15 more
Factory is an agent-native software development platform whose "Droid" agents plan, build, review, test, and ship production software across tools like the CLI, desktop, web, Slack, Microsoft Teams, Jira, Linear, and CI.
AI & Machine LearningDeveloper ToolsSaaSSan Francisco, US
Matan Grinberg(Founder)inEno Reyes(Founder)in
Co-investorsAbstract VenturesBBQ CapitalBoxGroupCoral CapitalGTM CapitalKhosla Ventures+17 more
Getlabs provides at-home lab sample collection, sending phlebotomists to patients to draw blood and collect samples for lab tests ordered by their providers.
Digital HealthHealthtechMedical DevicesMiami, US
Kyle Michelson(Founder)inClaire Hough(Chief Executive Officer)inMatt Bettonville(Director)David Shin(Director)Timothy Connors(Director)
Co-investorsCity LightEvolution VC PartnersPeterson VenturesRosecliff VenturesSand Hill AngelsKarlin Asset Management+4 more
Harmonic builds an advanced reasoning engine, a mathematical and computational tool for solving complex problems across scientific and technical domains.
AI & Machine LearningDeep Tech
Tudor Achim(Founder)inVlad Tenev(Founder)inVlad Tenev Tudor Achim(Founder)
Co-investorsBlossom CapitalFirestreak VenturesGreatPoint VenturesIndex VenturesKleiner PerkinsParadigm+8 more
Neurotechnology company developing implantable brain-computer interfaces for people with paralysis and vision loss.
BiotechFremont, US
ELON MUSK(Executive Officer)inBen Rapoport(Founder)Benjamin Rapoport(Founder)DJ Seo(Founder)Dongjin Seo(Founder)Elon Musk(Founder)
Co-investors1802 VenturesAdvaita CapitalAliya Capital PartnersAurum Venture PartnersBeyond CapitalCraft Ventures+37 more
NewLimit develops epigenetic reprogramming medicines to extend healthspan and treat age-related diseases at the intersection of computer science and biotechnology.
AI & Machine LearningBiotechLongevitySouth San Francisco, US
Brian Armstrong(Founder)inBlake Byers(Founder)inJacob Kimmel(Founder)inMichael Polansky(Executive Officer)
BoardZavain Dar(Director)in
Co-investorsS32Valor Equity Partners8VCAbstract Venturesage1Beyond Capital+15 more
RNA therapeutics company with a chip-based mRNA manufacturing platform; acquired by Medici Therapeutics in November 2025.
BiotechEmeryville, US
Igor Khandros(Executive Officer, Director)
Co-investors+ND CapitalARCH Venture PartnersBluebird VenturesCraft VenturesFounders FundParadigm+2 more
Kyle Vogt(Founder)inLuke Holoubek(Founder)Paril Jain(Founder)
Co-investorsSpark CapitalSV Angel
Vial develops first- and best-in-class biologic therapeutics — including RNA, antibody, and small molecule programs — for immunology and inflammatory disorders, using AI-driven target discovery and molecule design.
AI & Machine LearningBiotechHealthtech
Andrew Brackin(Founder)Simon Burns(Founder)
Co-investorsBoxGroupGeneral Catalyst
.png)
Vial develops first- and best-in-class biologics — including RNA, antibody, and small molecule programs — using AI-driven target discovery, molecule design, and high-throughput experimental validation, focused on immunology and inflammatory disorders.
AI & Machine LearningBiotechDigital HealthSan Francisco, US
Simon Burns(Founder)in
Co-investorsATEL VenturesGeneral Catalyst
Regard builds an AI clinical insights platform that reviews EHR data to suggest diagnoses and draft clinical notes for physicians.
Eli Ben-Joseph(Founder)Nate Wilson(Founder)Thomas Moulia(Founder)
Co-investorsMachina VenturesPLG VenturesCalibrate VenturesFoundryLux CapitalOak HC/FT+4 more
x.ai builds frontier AI reasoning models, real-time voice AI, and generative media systems.
AI & Machine LearningDeep TechDeveloper ToolsEnterprise SoftwarePalo Alto, US
Yuhuai (Tony) Wu(Founder)inDennis Mortensen(Executive Officer, Director)Alex Poon(Director)Greg Yang(Founder)inGuodong Zhang(Founder)inIgor Babuschkin(Founder)in
Co-investors7percent VenturesAbstract VenturesAccess Ventures (New York)Aglae VenturesAmity VenturesAndreessen Horowitz+71 more
Xaira develops AI and machine learning tools for drug discovery and protein design, serving pharmaceutical and biotech companies.
AI & Machine LearningBiotechMedical DevicesSouth San Francisco, US
Hetu Kamisetty(Founder)Marc Tessier-Lavigne(Founder)inDr. Ci Chu(Chief Discovery Officer)Dr. Bo Wang(Chief AI Scientist)Dr. Ian McCaffery(SVP, Translational Science and Early Clinical Development)Bob Nelsen(Founder)
Co-investorsARCH Venture PartnersBreyer CapitalDeviation CapitalF-Prime CapitalForesite CapitalLongwood Fund+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.